FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

32423711000001108: Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 01-Apr 2016. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
1885261000001117 Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
1885271000001110 Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction not available true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose Is a Mometasone 50micrograms/actuation nasal spray 140 dose true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose Has AMP Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose Has specific active ingredient Mometasone furoate true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose Has dispensed dose form Spray dose form true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose Legal category Prescription only medicine - legal category (qualifier value) true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose Discontinued indicator Never discontinued false Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose Is a Actual medicinal product pack true Inferred relationship Existential restriction modifier
Mometasone 50micrograms/dose nasal spray (Kent Pharma (UK) Ltd) 140 dose Discontinued indicator Discontinued AMPP(qualifier value) true Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group

This concept is not in any reference sets

Back to Start